NDC 58605-423
Maxiphen DM
Guaifenesin, Phenylephrine Hydrochloride, And Dextromethorphan Hydrobromide
Maxiphen DM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Mcr American Pharmaceuticals, Inc.. The primary component is Guaifenesin; Phenylephrine Hydrochloride; Dextromethorphan Hydrobromide.
| Product ID | 58605-423_1a720629-daee-4f54-b8ed-6d0d69c9d1cd |
| NDC | 58605-423 |
| Product Type | Human Otc Drug |
| Proprietary Name | Maxiphen DM |
| Generic Name | Guaifenesin, Phenylephrine Hydrochloride, And Dextromethorphan Hydrobromide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-03-31 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | MCR American Pharmaceuticals, Inc. |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE |
| Active Ingredient Strength | 400 mg/1; mg/1; mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 58605-423-01
100 TABLET in 1 BOTTLE, PLASTIC (58605-423-01)
| Marketing Start Date | 2008-03-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 58605-423-01 [58605042301]
Maxiphen DM TABLET
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-03-31 |
| Marketing End Date | 2013-09-30 |
| Inactivation Date | 2019-11-13 |
| Reactivation Date | 2020-05-20 |
NDC 58605-423-02 [58605042302]
Maxiphen DM TABLET
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-03-31 |
| Marketing End Date | 2013-09-30 |
| Inactivation Date | 2019-11-13 |
| Reactivation Date | 2020-05-20 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 400 mg/1 |
OpenFDA Data
| SPL SET ID: | 82f1f3c2-5aa1-4508-a585-fa109c66a120 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
NDC Crossover Matching brand name "Maxiphen DM" or generic name "Guaifenesin, Phenylephrine Hydrochloride, And Dextromethorphan Hydrobromide"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58605-423 | Maxiphen DM | Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
| 63824-515 | Mucinex Fast-Max | Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
Trademark Results [Maxiphen DM]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MAXIPHEN DM 78330862 2953702 Dead/Cancelled |
AMBI Pharmaceuticals, Inc. 2003-11-20 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.